Skip to main content

Table 1 The association between lncRNA HOXA11-AS expression and clinicopathologic factors in NSCLC patients

From: Overexpression of lncRNA HOXA11-AS promotes cell epithelial–mesenchymal transition by repressing miR-200b in non-small cell lung cancer

Clinicopathologic factors Patients number LncRNA HOXA11-AS expression P-value
Lower (n = 40) Higher (38)
Sex 0.380
 Male 47 26 21  
 Female 31 14 17  
Age 0.621
 ≤60 45 22 23  
 >60 33 18 15  
Smoking index 0.718
 Yes 49 24 25  
 No 29 16 13  
Tumor size (cm) 0.500
 <3 40 22 18  
 >3 38 18 20  
Histological differentiation 0.233
 High and moderate 32 19 13  
 Lower 46 21 25  
Histology 0.816
 Squamous carcinoma 35 18 17  
 Adenocarcinoma 33 16 17  
 Other type 10 6 4  
Lymph node metastasis 0.011**
 Negative 34 23 11  
 Positive 44 17 27  
TNM stage 0.007**
 I–II 43 28 15  
 III 35 12 23  
  1. TNM tumour-node-metastasis staging system
  2. ** P < 0.05